Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
about
Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@en
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@nl
type
label
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@en
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@nl
prefLabel
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@en
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@nl
P2860
P356
P1476
Aging and lymphocyte changes b ...... n multiple sclerosis patients.
@en
P2093
Elizabeth A Mills
Yang Mao-Draayer
P2860
P304
1352458518775550
P356
10.1177/1352458518775550
P577
2018-05-01T00:00:00Z